Genome Editing Technologies: Defining a Path to Clinic
Jacqueline Corrigan‐Curay(National Institutes of Health), Feng Zhang(Broad Institute), Frederic D. Bushman(University of Pennsylvania), Eugene Rosenthal(National Institutes of Health), Robert Jambou(National Institutes of Health), Paula M. Cannon(University of Southern California), Donald B. Kohn(University of California, Los Angeles), Michel Sadelain(Columbia University Irving Medical Center), Andrew M. Scharenberg(CTI BioPharma (Italy)), Morad Hassani(National Institutes of Health), Dana Carroll(University of Utah), Christof von Kalle(Luxembourg Institute of Health), Toni Cathomen(University of Freiburg), Gang Bao(Georgia Institute of Technology), Aparna Singh(National Institutes of Health), Marina O’Reilly(National Institutes of Health), J. Keith Joung(Massachusetts General Hospital), David B. Roth(University of Miami), Matthew H. Porteus(Lucile Packard Children's Hospital)
DSpace@MIT (Massachusetts Institute of Technology)
December 1, 2016
Cited by 0
Related Papers
QIIME allows analysis of high-throughput community sequencing data
|Nature Methods|2010|36k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
DNA targeting specificity of RNA-guided Cas9 nucleases
|Nature Biotechnology|2013|5k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k